How have CYBG shares performed in 2023?

VanEck Bionic Engineering UCITS ETF's stock was trading at GBX 16.40 at the beginning of the year. Since then, CYBG stock has decreased by 10.7% and is now trading at GBX 14.65. View the best growth stocks for 2023 here .

Is VanEck Bionic Engineering UCITS ETF a good dividend stock?

VanEck Bionic Engineering UCITS ETF (LON:CYBG) pays an annual dividend of GBX 0.03 per share and currently has a dividend yield of 2.25%. Read our dividend analysis for CYBG .

What other stocks do shareholders of VanEck Bionic Engineering UCITS ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Bionic Engineering UCITS ETF investors own include National Australia Bank (NAB) , G-III Apparel Group (GIII) , Alphabet (GOOG) , Ionis Pharmaceuticals (IONS) , Svenska Handelsbanken AB (publ) (SVNLY) , Western Union (WU) , ADT (ADT) , Agenus (AGEN) , ASGN (ASGN) and AutoWeb (AUTO) .

How do I buy shares of VanEck Bionic Engineering UCITS ETF?

Shares of CYBG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

VanEck Bionic Engineering UCITS ETF Share Price, News & Analysis (LON:CYBG)

GBX 14.65

-0.19 (-1.29%)

(As of 11/28/2023 09:00 PM ET)

Compare

Today's Range: 14.65
▼
14.65
50-Day Range: 13.47
▼
15.42
52-Week Range: 13.47
▼
18.36

Volume: 100 shs
Average Volume: 3.18 million shs
Market Capitalization: £210.10 million

P/E Ratio: N/A
Dividend Yield: 0.20%
Price Target: N/A

Stock Analysis Chart Competitors Headlines

About VanEck Bionic Engineering UCITS ETF Stock (LON:CYBG)

CYBG PLC, through its subsidiaries, provides retail and business banking products and services to individuals and businesses under the Clydesdale Bank, Yorkshire Bank, B, and Virgin Money brands in the United Kingdom. It operates through SME Banking and Retail Banking segments. The SME Banking segment offers a range of banking products and services, including business current accounts; and secured and unsecured term loans, business overdrafts, and invoice and asset financing products and services. It also provides international trade services, such as import loans, export loans, documentary collections, currency guarantees, and letters of credit for securing trade; and current account facilities comprising debit cards, cheque books, regular statements, direct debits, and standing orders, as well as day to day and online banking services. This segment serves business customers in the small business, commercial, corporate, and structured finance markets. The Retail Banking segment offers personal current accounts, savings accounts, and term deposits; occupied mortgage loans and BTL loans, unsecured personal loans, and overdrafts, as well as credit card products; and insurance and investment products. The company was founded in 1838 and is based in Leeds, the United Kingdom.

CYBG Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CYBG Stock News Headlines

November 20, 2023 | lse.co.uk

Vaneck Sustainable World Ew Ucits Etf Share Chat

July 14, 2023 | uk.investing.com

VanEck Global Mining UCITS A (GIGB)

November 29, 2023 | Autonomix (Ad)

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

June 4, 2023 | uk.investing.com

VanEck Genomics and Healthcare Innovators UCITS ETF (CURE)

May 20, 2023 | seekingalpha.com

GDX VanEck Gold Miners ETF

April 6, 2023 | investing.com

VanEck Hydrogen Economy UCITS ETF A USD (HDRO)

March 6, 2023 | uk.finance.yahoo.com

VanEck Bionic Engineering UCITS ETF (CYBG.L)

December 13, 2022 | msn.com

Silicon Valley lawmaker tells big tech it's not their ‘responsibility' to fact-check New York Post, media

November 29, 2023 | Autonomix (Ad)

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

November 21, 2022 | msn.com

Virgin Money reveals 10% pay rise for thousands of staff but warns of 'volatile environment’

October 17, 2022 | afr.com

NAB’s class-action nemesis targets Link Group

October 5, 2022 | msn.com

Experts Explain Hyperinflation and 8 Ways to Prepare and Protect Your Money

September 24, 2022 | msn.com

Kenton Kirkland Bringing Speed, Size, and Smarts to Tallahassee

September 9, 2022 | au.finance.yahoo.com

Virgin Money UK PLC (42YA.SG)

September 5, 2022 | fool.com.au

Why these 4 ASX shares have been slammed today

August 3, 2022 | reuters.com

UPDATE 1-Virgin Money UK raises margin forecast on higher interest rates

August 3, 2022 | uk.news.yahoo.com

Glasgow-based bank 'not yet seeing distress' as cost-of-living crisis deepens

August 2, 2022 | nasdaq.com

Virgin Money UK raises margin forecast on higher interest rates

July 20, 2022 | msn.com

UK pay falls at fastest rate on record as inflation bites – as it happened

July 18, 2022 | fool.com.au

Why the Clydesdale Bank CYBG PLC CDI 1:1 share price is looking up

June 30, 2022 | thetimes.co.uk

Virgin Money shareholders to scoop £75m in buyback

June 17, 2022 | financialpost.com

UK Needs to Put More 'Energy' Into Trade, Says Ex-NatWest Boss

June 6, 2022 | msn.com

£200m Virgin Money fund will help farmers move to net zero

May 7, 2022 | uk.finance.yahoo.com

Virgin Money profits lifted by rate rises but fires warning on outlook

May 5, 2022 | ft.com

Live news: Kellogg boosts sales forecast as higher prices offset surging inflation

May 5, 2022 | ft.com

Live news: Inflation in Turkey soars to almost 70% as cost of food and transport rises

May 5, 2022 | msn.com

Clydesdale owner Virgin Money boosted by record credit card sign-ups as profits jump

See More Headlines

Receive CYBG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VanEck Bionic Engineering UCITS ETF and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: LON
Industry: Banks - Regional - Europe
Sub-Industry: N/A
Sector: Finance
Current Symbol: LON:CYBG
CUSIP: N/A
CIK: N/A
Web: www.cybg.com
Phone: +44-141-2324763
Fax: N/A
Employees: 5,762
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: 0.00
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: £1.24 billion
Price / Sales: 0.17
Cash Flow: GBX 109.54 per share
Price / Cash Flow: 0.13
Book Value: GBX 355.10 per share
Price / Book: 0.04

Miscellaneous

Outstanding Shares: 1,434,489,984
Free Float: N/A
Market Cap: £210.10 million
Optionable: Not Optionable
Beta: N/A

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

Mr. David Joseph Duffy B.B.S. (Age 58)
MA, CEO & Exec. Director
Mr. Ian Stuart Smith (Age 52)
Group CFO & Exec. Director
Mr. Fraser Ingram
Interim Group Chief Operating Officer
Mr. Andrew Downey
Head of Investor Relations
Mr. James Richard Peirson (Age 41)
Group Gen. Counsel & Company Sec.

Key Competitors

View All Competitors

CYBG Stock Analysis - Frequently Asked Questions

How have CYBG shares performed in 2023?: VanEck Bionic Engineering UCITS ETF's stock was trading at GBX 16.40 at the beginning of the year. Since then, CYBG stock has decreased by 10.7% and is now trading at GBX 14.65.
View the best growth stocks for 2023 here.
Is VanEck Bionic Engineering UCITS ETF a good dividend stock?: VanEck Bionic Engineering UCITS ETF (LON:CYBG) pays an annual dividend of GBX 0.03 per share and currently has a dividend yield of 2.25%.
Read our dividend analysis for CYBG.
What other stocks do shareholders of VanEck Bionic Engineering UCITS ETF own?: Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Bionic Engineering UCITS ETF investors own include National Australia Bank (NAB), G-III Apparel Group (GIII), Alphabet (GOOG), Ionis Pharmaceuticals (IONS), Svenska Handelsbanken AB (publ) (SVNLY), Western Union (WU), ADT (ADT), Agenus (AGEN), ASGN (ASGN) and AutoWeb (AUTO).
How do I buy shares of VanEck Bionic Engineering UCITS ETF?: Shares of CYBG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:CYBG) was last updated on 11/29/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial